Virinchi Limited
All news and filings related to Virinchi Limited.
View all news & filings- Low impact
Virinchi Limited Announces 39th AGM on Sept 30, 2026, with E-voting Facility
Virinchi Limited will hold its 39th AGM on September 30, 2026, at 12:30 PM IST via video conference. The cut-off date for voting eligibility is September 23, 2026. Remote e-voting is open from September 26 to September 29, 2026.
Read the summary - Low impact
Virinchi Ltd. Dispatches Annual Report for FY26; AGM on Sep 30
Virinchi Limited has dispatched its Annual Report for FY 2025-26. The company will hold its Annual General Meeting on September 30, 2026, at 12:30 PM via VC/OAVM. Shareholders are also reminded to update their KYC details, especially those holding physical shares.
Read the summary - Medium impact
Virinchi Limited Announces 37th AGM on Sept 30, 2026, to Discuss FY26 Results & Director Re-appointment
Virinchi Limited will hold its 37th Annual General Meeting on September 30, 2026, via VC/OAVM. The meeting will review the audited financial statements for FY 2025-26. A key agenda item is the re-appointment of director Mr. V. Satyanarayana, who retires by rotation. E-voting will be open from September 26 to September 29, 2026.
Read the summary - Low impact
Virinchi Limited Publishes Notice for Special Window on Share Transfer
Virinchi Limited announced a special window for transferring and dematerializing physical shares, open from February 05, 2026, to February 04, 2027. This applies to shares purchased before April 01, 2019, with specific conditions regarding transfer lodgement.
Read the summary - Low impact
Virinchi Limited Board Approves AGM on Sep 30, 2026; Reappoints Director
Virinchi Limited will hold its 37th AGM on September 30, 2026, via Video Conferencing. The Board approved the annual reports for FY26 and the re-appointment of Director Mr. Satyanarayana Vedula, who retires by rotation.
Read the summary - Low impact
Virinchi Ltd. Publishes Unaudited Financial Results for Q1 FY27
Virinchi Limited announced its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The results were published in "Financial Express" and "Nava Telangana" on August 15, 2026.
Read the summary - Medium impact
Virinchi Shareholders Approve Acquisition of Healthcare Business
Virinchi Limited shareholders approved the acquisition of the healthcare business division of its subsidiary, Virinchi Health Care Private Limited, via slump sale. The resolution was passed through postal ballot and e-voting, with the approval deemed effective on August 10, 2026. Voting results confirmed the acquisition's approval.
Read the summary - Medium impact
Virinchi Limited Shareholders Approve Key Resolutions via Postal Ballot
Virinchi Limited shareholders approved three resolutions via postal ballot and e-voting on July 14, 2026. The resolutions included approving loans and material related party transactions with Virinchi Health Care and Vivo Bio Tech. Over 90% of votes polled favored each resolution.
Read the summary - Low impact
Virinchi Limited Revises Audited Financials for FY26 Due to XBRL Errors
Virinchi Limited revised its consolidated and standalone audited financial results for the year ended March 31, 2026. Corrections were made to standalone EPS for discontinued operations, segment details, consolidated PAT figures, and consolidated yearly EPS. This follows a clarification request from NSE.
Read the summary - Low impact
Virinchi Limited Reports Nil Share Transfer Requests for June 2026
Virinchi Limited reported no re-lodgement requests for physical share transfers in June 2026 as per SEBI guidelines. The company's Registrar and Share Transfer Agent confirmed zero activity in received, processed, approved, or rejected requests for the period.
Read the summary - Low impact
Virinchi Limited Submits SEBI Compliance Certificate for Q1 FY27
Virinchi Limited submitted a certificate of compliance for the period April 01, 2026, to June 30, 2026, as per SEBI regulations. The certificate confirms timely processing of dematerialization requests by the Registrar and Share Transfer Agent, Aarthi Consultants Private Limited.
Read the summary - Low impact
Virinchi Limited: Newspaper Publication for Postal Ballot & E-Voting
Virinchi Limited published a newspaper advertisement on July 11, 2026, concerning a Notice of Postal Ballot and E-Voting. The notice, published in "Financial Express" and "Nava Telangana," is in compliance with SEBI regulations. The advertisements are also available on the company's website.
Read the summary - Medium impact
Virinchi Limited Announces Postal Ballot for Healthcare Business Acquisition
Virinchi Limited seeks shareholder approval via postal ballot to acquire its healthcare business division for ₹100 Crores. E-voting runs from July 12 to August 10, 2026, with results by August 12, 2026. The acquisition aims to create an AI-first healthcare platform.
Read the summary - High impact
Virinchi to acquire Healthcare Business from Subsidiary for ₹100 Cr via Slump Sale
Virinchi Limited will acquire the "Bristlecone Hospitals" business from its subsidiary VHCPL for ₹100 Crores via a slump sale. This strategic move aims to create an AI-first healthcare platform, enhancing patient outcomes and scalability. The transaction is effective from April 1, 2026, and requires shareholder approval.
Read the summary - Medium impact
Virinchi Limited Acquires Healthcare Business from Subsidiary for ₹100 Crore
Virinchi Limited approved acquiring the "Bristlecone Hospitals" business from its subsidiary VHCPL for ₹100 Crores via slump sale. The deal, effective April 1, 2026, aims to create an AI-first healthcare platform. VHCPL's recent turnovers were ₹13,314.85 Lakhs, ₹10,414.98 Lakhs, and ₹8,299.05 Lakhs.
Read the summary - Medium impact
Virinchi Ltd. Seeks Shareholder Approval for Loans and Related Party Transactions
Virinchi Limited is seeking shareholder approval via postal ballot for loans up to ₹50 crore to a subsidiary and related party transactions totaling ₹60 crore with Virinchi Health Care Private Limited and ₹30 crore with Vivo Bio Tech Limited. E-voting runs from June 15 to July 14, 2026.
Read the summary - Low impact
Virinchi Limited Allots 20 Lakh Equity Shares on Warrant Conversion
Virinchi Limited allotted 20,00,000 equity shares at Rs. 25 each upon conversion of warrants issued on preferential basis. The company received Rs. 3.75 crore in application money. This allotment increases the company's issued and subscribed share capital to Rs. 112.56 crore.
Read the summary - Medium impact
Virinchi Q4FY26 Results: Revenue Up 16.55%, PAT Declines Amidst Write-off
Virinchi Limited reported Q4FY26 standalone revenue of ₹44.45 crore, up 16.55% YoY. Full-year FY26 revenue rose 19.53% to ₹183.38 crore. PAT for Q4FY26 was a loss of ₹8.10 crore due to an ₹8.43 crore write-off. FY26 PAT was ₹13.98 crore. Consolidated Q4FY26 revenue was ₹67.31 crore with a net loss of ₹15.69 crore.
Read the summary - Low impact
Virinchi Limited Publishes Audited Financial Results for FY26
Virinchi Limited has published its audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026. The results were advertised in "Financial Express" and "Nava Telangana" on May 30, 2026.
Read the summary - Medium impact
Virinchi Limited declares Audited Standalone & Consolidated Financial Results for FY26
Virinchi Limited announced its audited standalone and consolidated financial results for the year ended March 31, 2026. The company's statutory auditors issued an unmodified opinion on these results. The announcement detailed financial performance across various segments including SaaS, IT services, healthcare, and payment services.
Read the summary - Medium impact
Virinchi Limited Board Approves Audited FY26 Standalone & Consolidated Financial Results
Virinchi Limited's Board approved audited standalone and consolidated financial results for the year ended March 31, 2026. Standalone revenue was ₹16,400.49 Lakhs and consolidated revenue was ₹24,436.44 Lakhs. The company also detailed cash flow statements and the statement of assets and liabilities as of March 31, 2026.
Read the summary - Low impact
Virinchi Ltd Allots 9.1 Lakh Equity Shares on Warrant Conversion
Virinchi Limited allotted 9,10,476 equity shares at ₹28 each upon conversion of warrants. This increases the company's issued and subscribed share capital to ₹1,10,55,73,720. The allotment was made to IT Peer Technologies LLC.
Read the summary - Low impact
Virinchi Limited Promoters Declare No Share Encumbrance as of March 31, 2026
Virinchi Limited promoters and PAC, holding 4,36,25,538 equity shares as of March 31, 2026, have declared no new share encumbrances for the financial year ended March 31, 2026. This filing is in accordance with SEBI Takeover Regulations.
Read the summary - Low impact
Virinchi Limited: No Physical Share Transfer Requests Re-lodged in March 2026
Virinchi Limited reported that no physical share transfer requests were re-lodged in March 2026, as per SEBI's special window. The company's Registrar and Share Transfer Agent confirmed zero requests received, processed, approved, or rejected during the period.
Read the summary - Low impact
Virinchi Ltd Allots 8.5 Lakh Equity Shares on Warrant Conversion
Virinchi Limited allotted 8,50,000 equity shares at Rs. 28 per share upon conversion of warrants. The company received Rs. 1.785 crore in application money. This allotment increases the issued and subscribed share capital to Rs. 109.65 crore.
Read the summary - Low impact
Virinchi Limited Files SEBI Depositories Compliance Certificate
Virinchi Limited submitted a compliance certificate for Q4 FY26 (Jan 01 - Mar 31, 2026) under SEBI (Depositories and Participants) Regulations, 2018. The Registrar and Transfer Agent confirmed dematerialization and compliance within stipulated timelines.
Read the summary - Low impact
Virinchi Ltd. Publishes Newspaper Notice for Special Window for Share Transfers
Virinchi Limited published a notice on April 6, 2026, in Financial Express and Nava Telangana about a special window for transferring and dematerializing physical shares. This aligns with SEBI's circular dated January 30, 2026. The company submitted the publication to BSE and NSE.
Read the summary - Low impact
Virinchi Limited: Trading Window Closed from April 1, 2026, for Q4 FY26 Results
Virinchi Limited will close its trading window from April 1, 2026. The closure is in accordance with SEBI regulations and the company's insider trading code. It will remain shut until 48 hours after the announcement of the audited financial results for the fourth quarter and year ended March 31, 2026.
Read the summary - Medium impact
Virinchi Health Care Private Limited ceases to be wholly-owned subsidiary
Virinchi Limited's subsidiary, Virinchi Health Care Private Limited (VHPL), is no longer wholly-owned. Promoter Viswanath Kompella now holds 49% after converting 52,22,000 warrants issued on March 3, 2026. VHPL's FY25 turnover was ₹92.54 crore.
Read the summary - Low impact
Virinchi Limited Allots 13.15 Lakh Shares on Warrant Conversion
Virinchi Limited has allotted 13,15,715 equity shares upon conversion of warrants issued on a preferential basis. The issue price was ₹28 per share, with ₹2,76,30,015 received as application money. This allotment increases the company's issued and subscribed share capital to ₹108.79 crore.
Read the summary - Low impact
Virinchi Limited Publishes Notice for Special Window for Share Transfer
Virinchi Limited has published a notice in newspapers for a special window to re-lodge transfer requests for physical shares. This initiative is in line with SEBI guidelines to facilitate the transfer and dematerialisation of physical securities. The notice aims to assist shareholders in processing their requests.
Read the summary - Medium impact
Virinchi Limited Publishes Q3 FY26 Un-Audited Financial Results
Virinchi Limited reported Q3 FY26 un-audited standalone revenue of ₹334.88 crore and nine-month revenue of ₹1,047.65 crore. Nine-month profit after tax was ₹76.85 crore, and Q3 profit after tax was ₹27.31 crore. The company targets ₹1,400 crore revenue for FY27 through organic growth and acquisitions.
Read the summary - Low impact
Virinchi Limited Allots 20.7 Lakh Shares on Warrant Conversion
Virinchi Limited allotted 20,70,000 equity shares upon conversion of warrants issued on preferential basis. The shares were allotted to Vivo Bio Tech Limited at ₹28 per share, with the company receiving ₹4.34 crore. This increases the issued share capital to ₹107.48 crore.
Read the summary - Medium impact
Virinchi Limited Reports Q3 FY26 Un-audited Standalone & Consolidated Financial Results
Virinchi Limited approved its un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Standalone net profit after tax was ₹838.42 Lakhs for the quarter and ₹2,208.20 Lakhs for nine months. Consolidated net profit after tax was ₹159.65 Lakhs for the quarter and ₹(1170.05) Lakhs for nine months.
Read the summary - Medium impact
Virinchi Ltd Q3FY26 Standalone Profit ₹838 Crore, Consolidated ₹160 Crore
Virinchi Limited reported standalone revenue of ₹4,283.70 Lakhs and a Net Profit After Tax of ₹838.42 Lakhs for Q3FY26. Consolidated revenue was ₹7,688.82 Lakhs with a Net Profit After Tax of ₹159.65 Lakhs. For the nine months ended December 31, 2025, standalone Net Profit After Tax was ₹2,208.20 Lakhs, while consolidated Net Profit After Tax was ₹(1,170.05) Lakhs.
Read the summary - Medium impact
Virinchi Limited Allots 17.14 Lakh Shares on Warrant Conversion
Virinchi Limited has allotted 17,14,285 equity shares at ₹28 each upon conversion of warrants issued on preferential basis. The allotment was made to Vivo Bio Tech Limited. This conversion increases the company's issued and subscribed share capital to ₹1,05,41,11,810.
Read the summary - Low impact
Virinchi Limited Allots 10.5 Lakh Shares on Warrant Conversion
Virinchi Limited allotted 10,50,000 equity shares upon conversion of warrants issued on a preferential basis. The issue price was ₹25 per share. This increases the company's issued and subscribed share capital to ₹103.70 crore.
Read the summary - Medium impact
Virinchi Limited publishes Newspaper Advertisement for Postal Ballot & E-Voting
Virinchi Limited published a notice for Postal Ballot & E-Voting on Jan 24, 2026. The company's board approved the merger of its subsidiary, Virinchi Technologies, with Virinchi Limited. A share swap ratio of 104:10 (Virinchi Ltd:Virinchi Technologies) has been approved. The merger is expected to be completed within 104 days.
Read the summary - Medium impact
Virinchi Limited Seeks Shareholder Approval for Subsidiary's Convertible Warrant Issue
Virinchi Limited is seeking shareholder approval via postal ballot for its subsidiary, Virinchi Health Care Private Limited, to issue up to 52.22 lakh convertible warrants to promoter Mr. Viswanath Kompella. The issue is at ₹15 per warrant, based on a ₹312.08 crore enterprise valuation, for a total of ₹7.83 crore. E-voting runs from January 25 to February 23, 2026.
Read the summary - Medium impact
Virinchi Board Approves Promoter's Preferential Allotment in Subsidiary
Virinchi Limited's Board approved a preferential allotment of Convertible Equity Warrants to Promoter Mr. Viswanath Kompella in its material subsidiary, Virinchi Health Care Private Limited. The investment, valued at ₹312.08 crore, will see up to 49% equity stake via warrants priced at ₹15 each, convertible within 36 months.
Read the summary - Low impact
Virinchi Ltd: Certificate Under SEBI Regulations For Q3 FY26
Virinchi Limited submitted a certificate for the period October 1, 2025, to December 31, 2025, as per SEBI (Depositories and Participants) Regulations, 2018. The company confirmed compliance with dematerialization procedures through its Registrar and Transfer Agent.
Read the summary - Low impact
Virinchi Limited Reports NIL Transfer Requests in Special Window
Virinchi Limited reported NIL transfer requests for physical shares during the special window from December 01, 2025, to January 06, 2026. No requests were received, processed, or approved, as per the report from their Registrar and Share Transfer Agent.
Read the summary - Medium impact
Virinchi Ltd Allots 74 Lakh Warrants to Vivo Bio Tech at ₹28/Share
Virinchi Limited approved the allotment of 74 Lakh convertible equity warrants to Vivo Bio Tech Limited at ₹28 per warrant. The company received 25% of the issue price, amounting to ₹5.18 crore. Warrants are convertible into equity shares within 18 months.
Read the summary - Medium impact
Virinchi Ltd Allots 86 Lakh Warrants to Vivo Bio Tech at ₹28
Virinchi Limited has allotted 86,00,000 convertible equity warrants to Vivo Bio Tech Limited at ₹28 per warrant. The allotment follows shareholder approval and regulatory in-principle approvals. Warrants are convertible into equity shares within 18 months upon receipt of the balance subscription amount.
Read the summary - Medium impact
Virinchi Ltd Allots 40 Lakh Warrants at ₹28 Each to IT Peer Technologies
Virinchi Limited approved the allotment of 40,00,000 convertible equity warrants to IT Peer Technologies LLC at ₹28 per warrant. The allotment is on a preferential basis following shareholder and exchange approvals. Warrants are convertible into equity shares within 18 months upon payment of the balance subscription amount.
Read the summary - Low impact
Virinchi Limited: Trading Window Closed Jan 1, 2026 for Q4 FY26 Results
Virinchi Limited will close its trading window from January 01, 2026. The window will reopen 48 hours after the declaration of the un-audited financial results for the quarter ended December 31, 2025, as per SEBI regulations.
Read the summary - Low impact
Re-lodgement of Transfer Requests of Physical Shares
Virinchi Limited announces the re-lodgement of transfer requests of physical shares as per SEBI guidelines. No requests were processed during the reported month.
Read the summary - Low impact
Virinchi Limited: EGM Voting Results & Scrutinizer's Report
Virinchi Limited announced the voting results of EGM held on Nov 15, 2025. Two special resolutions were passed including approval of preferential allotment and revision of remuneration.
Read the summary - Medium impact
Virinchi Limited's EGM approves preferential warrant issue and advisor remuneration revision
Virinchi Limited's EGM on November 15, 2025, approved a preferential issue of convertible equity warrants and revised advisor remuneration. Voting results are expected by November 18, 2025.
Read the summary - Medium impact
Virinchi Limited Announces Un-Audited Financial Results for Q2 & Half Year Ended Sept 30, 2025
Virinchi Limited declares Q2 & Half Year results: Consolidated revenue at ₹1,825.11 Lakhs, loss at ₹-1,366.64 Lakhs. Standalone revenue ₹4,551.34 Lakhs, profit before tax ₹958.83 Lakhs, and profit ₹756.71 Lakhs.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio